Clinical Trial Update: The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sitagliptin for COVID-19 in patients with type 2 diabetes (diabetes mellitus) with unclear current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of Milan | Conditions: Covid19, Diabetes Mellitus, Type 2 | Phase 3 | Status: UNKNOWN